Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa

scientific article published in May 1995

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.69.5.3108-3116.1995
P932PMC publication ID189012
P698PubMed publication ID7707539

P50authorElliott D. KieffQ43399614
P2093author name stringC Miller
J Lin
E S Robertson
B Tomkinson
E Johannsen
S Grossman
P2860cites workTAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasmsQ24320364
A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1Q24323156
Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteinsQ27861094
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogeneQ28116777
Scissors-grip model for DNA recognition by a family of leucine zipper proteinsQ28272775
CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elementsQ29618195
Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory elementQ33810690
DNA sequence and expression of the B95-8 Epstein-Barr virus genome.Q34245077
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformationQ34324039
The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoterQ34355226
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cellsQ34366291
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.Q34625121
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding proteinQ35648541
Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.Q35829475
The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.Q35830605
Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.Q35832104
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cellsQ36263086
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformationQ36575274
The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding proteinQ36581891
Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformationQ36622140
An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitroQ36628631
The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.Q36635773
Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.Q36651589
The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressorQ36652805
Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testisQ36682511
The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessentialQ36685081
The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.Q36686042
Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.Q36686055
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivationQ36689004
Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoterQ36697355
Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitroQ36697392
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genesQ36782491
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23Q36806063
The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalizationQ36806641
Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.Q36810617
An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activatorQ36820857
A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.Q36828303
Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expressionQ36828413
The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformationQ36828608
A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytesQ36866232
Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activityQ36881880
A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virusQ36885800
Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitroQ37409177
Recognition sequence of a highly conserved DNA binding protein RBP-J kappaQ38309890
Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cellsQ40040836
Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive elementQ40042560
Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.Q40049217
Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.Q40108807
Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.Q40793575
Biochemical and immunological characterization of the DNA binding protein (RBP-J kappa) to mouse J kappa recombination signal sequenceQ41099910
Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibodyQ41479044
Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequencesQ41543823
Suppressor of Hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fatesQ43575150
Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytesQ43679392
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative diseaseQ43936463
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappaQ45781476
Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cellsQ45834584
Epstein-Barr virus latent gene expression during the initiation of B cell immortalizationQ45845786
Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteinsQ45851423
Early events in Epstein-Barr virus infection of human B lymphocytesQ45855126
The suppressor of hairless protein participates in notch receptor signalingQ47072502
The Drosophila homolog of the immunoglobulin recombination signal-binding protein regulates peripheral nervous system development.Q52444074
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.Q53541156
Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBVQ72756611
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectEpstein–Barr virusQ6900
P1104number of pages9
P304page(s)3108-3116
P577publication date1995-05-01
P1433published inJournal of VirologyQ1251128
P1476titleEpstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa
P478volume69

Reverse relations

cites work (P2860)
Q24682619A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa
Q40423684Activation of the Notch-regulated transcription factor CBF1/RBP-Jkappa through the 13SE1A oncoprotein
Q39601084Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation
Q38664787An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.
Q24675704BRCA1 is a component of the RNA polymerase II holoenzyme
Q39756123Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.
Q22008610CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex
Q35192797Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency
Q22010174Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C
Q38341023Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
Q38728190Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression
Q34234140Cytokine signaling and Epstein-Barr virus-mediated cell transformation
Q38337443Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
Q39392125Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements
Q38174306Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation
Q35862488EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes
Q35889902EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells
Q34552733EBNA3C coactivation with EBNA2 requires a SUMO homology domain
Q61450799EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation
Q36109083EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.
Q36535405EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes
Q60920702Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
Q59357136Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2
Q35685797Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.
Q36525145Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth
Q28074586Epstein-Barr Virus: Diseases Linked to Infection and Transformation
Q35539925Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.
Q39306073Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Q38353695Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
Q39882226Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
Q24675055Epstein-Barr virus and virus human protein interaction maps
Q39686312Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes.
Q24678677Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation
Q35008870Epstein-Barr virus in the pathogenesis of NPC.
Q37254393Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency
Q34328170Epstein-Barr virus infection and human malignancies
Q28082701Epstein-Barr virus latent genes
Q35891377Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain
Q28594944Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice
Q41063703Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Q34985686Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes
Q24537547Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.
Q39879529Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
Q37474974Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.
Q39594681Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription
Q39874105Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.
Q24540313Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
Q34782258Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines
Q34472101Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines
Q40594951Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity
Q34102722Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis
Q34872837Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities
Q34549944Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression
Q24681418Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1
Q33911878Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical
Q35014692Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth
Q37452130Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.
Q38303570Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis
Q35540042Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells
Q37132783Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth
Q35891360Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation
Q90095448Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival
Q37248930Epstein-Barr virus vectors for gene delivery to B lymphocytes
Q33787090Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site
Q34347958Epstein-barr virus-induced changes in B-lymphocyte gene expression
Q40288802Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors
Q33749934Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification
Q45729115High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors
Q34273467Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation
Q34998257Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9
Q33843211Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency
Q39588351Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells
Q33640843Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes
Q35865472Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals
Q33737793Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway
Q37217649MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.
Q64990535Manipulation of Epithelial Differentiation by HPV Oncoproteins.
Q39880772Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter.
Q34998243Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming
Q28117643Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha
Q34225554Molecular virology of Epstein-Barr virus
Q39577674Multiple functions within the Epstein-Barr virus EBNA-3A protein.
Q22254088NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
Q35008880Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy
Q36402940Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation
Q33604108Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.
Q40397055RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2.
Q39877574Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp).
Q40398026Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.
Q33786088Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
Q39591670Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus
Q54251658The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency.
Q28546003The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth
Q34711793The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
Q42702063The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter
Q34275895The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis
Q40588233The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein
Q24310605The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa)
Q34362138The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription
Q39748937Transcriptional Regulatory Properties of Epstein-Barr Virus Nuclear Antigen 3C Are Conserved in Simian Lymphocryptoviruses
Q34039189Viral latency and its regulation: lessons from the gamma-herpesviruses
Q24653900Viruses associated with human cancer
Q35867579oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.